NO20021330L - Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem - Google Patents

Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Info

Publication number: NO20021330L
Authority: NO; Norway
Prior art keywords: indoindolone; compounds; preparation; new; methods
Prior art date: 2001-03-19

Application number

NO20021330A

Other languages

English (en)

Other versions

NO20021330D0 (no

NO321890B1 (no

Inventor

Michel Wierzbicki

Marie-Francoise Boussard

Anne Rousseau

Jean Albert Boutin

Philippe Delagrange

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-19

Filing date

2002-03-18

Publication date

2002-09-20

2002-03-18 Application filed by Servier Lab filed Critical Servier Lab

2002-03-18 Publication of NO20021330D0 publication Critical patent/NO20021330D0/no

2002-09-20 Publication of NO20021330L publication Critical patent/NO20021330L/no

2006-07-17 Publication of NO321890B1 publication Critical patent/NO321890B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Psychology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20021330A 2001-03-19 2002-03-18 Nye indenoindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO321890B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0103667A FR2822153B1 (fr)	2001-03-19	2001-03-19	Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number	Publication Date
NO20021330D0 NO20021330D0 (no)	2002-03-18
NO20021330L true NO20021330L (no)	2002-09-20
NO321890B1 NO321890B1 (no)	2006-07-17

Family

ID=8861264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021330A NO321890B1 (no)	2001-03-19	2002-03-18	Nye indenoindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (24)

Country	Link
US (1)	US6844445B2 (no)
EP (1)	EP1245565B1 (no)
JP (1)	JP3886829B2 (no)
KR (1)	KR100453979B1 (no)
CN (1)	CN1185214C (no)
AR (1)	AR034861A1 (no)
AT (1)	ATE250578T1 (no)
AU (1)	AU780027B2 (no)
BR (1)	BR0200871A (no)
CA (1)	CA2378628C (no)
DE (1)	DE60200041T2 (no)
DK (1)	DK1245565T3 (no)
EA (1)	EA004711B1 (no)
ES (1)	ES2207629T3 (no)
FR (1)	FR2822153B1 (no)
HK (1)	HK1049159B (no)
HU (1)	HU226674B1 (no)
MX (1)	MXPA02002816A (no)
NO (1)	NO321890B1 (no)
NZ (1)	NZ517855A (no)
PL (1)	PL352866A1 (no)
PT (1)	PT1245565E (no)
SI (1)	SI1245565T1 (no)
ZA (1)	ZA200202220B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006047231B4 (de) *	2006-10-04	2009-02-12	Hemmerling, Hans-Jörg, Dr.	Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
ES2580702B1 (es)	2015-02-25	2017-06-08	Palobiofarma, S.L.	Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
CN111108105B (zh)	2017-09-22	2023-03-31	朱比兰特埃皮帕德有限公司	作为pad抑制剂的杂环化合物
PL3697785T3 (pl)	2017-10-18	2023-08-07	Jubilant Epipad LLC	Związki imidazopirydynowe jako inhibitory pad
KR20200085836A (ko)	2017-11-06	2020-07-15	주빌런트 프로델 엘엘씨	Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체
DK3704120T3 (da)	2017-11-24	2024-05-21	Jubilant Episcribe Llc	Heterocykliske forbindelser som prmt5-inhibitorer
EP3765453A1 (en)	2018-03-13	2021-01-20	Jubilant Prodel LLC	Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU166291A (sh) *	1990-10-16	1994-04-05	University Of Bath Claverton Down	Indenoindol jedinjenja

2001
- 2001-03-19 FR FR0103667A patent/FR2822153B1/fr not_active Expired - Fee Related
2002
- 2002-03-14 MX MXPA02002816A patent/MXPA02002816A/es active IP Right Grant
- 2002-03-18 DE DE60200041T patent/DE60200041T2/de not_active Expired - Fee Related
- 2002-03-18 JP JP2002073851A patent/JP3886829B2/ja not_active Expired - Fee Related
- 2002-03-18 NZ NZ517855A patent/NZ517855A/xx unknown
- 2002-03-18 ES ES02290668T patent/ES2207629T3/es not_active Expired - Lifetime
- 2002-03-18 CN CNB021075778A patent/CN1185214C/zh not_active Expired - Fee Related
- 2002-03-18 PT PT02290668T patent/PT1245565E/pt unknown
- 2002-03-18 EA EA200200263A patent/EA004711B1/ru unknown
- 2002-03-18 NO NO20021330A patent/NO321890B1/no not_active IP Right Cessation
- 2002-03-18 DK DK02290668T patent/DK1245565T3/da active
- 2002-03-18 SI SI200230003T patent/SI1245565T1/xx unknown
- 2002-03-18 EP EP02290668A patent/EP1245565B1/fr not_active Expired - Lifetime
- 2002-03-18 AR ARP020100952A patent/AR034861A1/es unknown
- 2002-03-18 AT AT02290668T patent/ATE250578T1/de not_active IP Right Cessation
- 2002-03-19 ZA ZA200202220A patent/ZA200202220B/xx unknown
- 2002-03-19 US US10/100,784 patent/US6844445B2/en not_active Expired - Fee Related
- 2002-03-19 HU HU0201024A patent/HU226674B1/hu not_active IP Right Cessation
- 2002-03-19 CA CA002378628A patent/CA2378628C/fr not_active Expired - Fee Related
- 2002-03-19 AU AU27469/02A patent/AU780027B2/en not_active Ceased
- 2002-03-19 KR KR10-2002-0014738A patent/KR100453979B1/ko not_active Expired - Fee Related
- 2002-03-19 PL PL02352866A patent/PL352866A1/xx not_active IP Right Cessation
- 2002-03-19 BR BR0200871-8A patent/BR0200871A/pt not_active IP Right Cessation
2003
- 2003-02-18 HK HK03101148.6A patent/HK1049159B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE60200041D1 (de)	2003-10-30
EP1245565A1 (fr)	2002-10-02
ES2207629T3 (es)	2004-06-01
JP2002322150A (ja)	2002-11-08
EA004711B1 (ru)	2004-06-24
CN1375490A (zh)	2002-10-23
CA2378628A1 (fr)	2002-09-19
KR100453979B1 (ko)	2004-10-20
FR2822153B1 (fr)	2003-10-31
CA2378628C (fr)	2007-07-10
PL352866A1 (en)	2002-09-23
US6844445B2 (en)	2005-01-18
US20020173531A1 (en)	2002-11-21
KR20020074420A (ko)	2002-09-30
EA200200263A3 (ru)	2002-12-26
NZ517855A (en)	2002-10-25
DE60200041T2 (de)	2004-06-09
NO20021330D0 (no)	2002-03-18
AU2746902A (en)	2002-09-26
HUP0201024A2 (hu)	2002-11-28
AU780027B2 (en)	2005-02-24
JP3886829B2 (ja)	2007-02-28
HK1049159B (zh)	2005-07-29
HK1049159A1 (en)	2003-05-02
NO321890B1 (no)	2006-07-17
HUP0201024A3 (en)	2003-12-29
SI1245565T1 (en)	2003-12-31
FR2822153A1 (fr)	2002-09-20
HU0201024D0 (no)	2002-05-29
EP1245565B1 (fr)	2003-09-24
HU226674B1 (en)	2009-06-29
MXPA02002816A (es)	2004-11-12
AR034861A1 (es)	2004-03-24
EA200200263A2 (ru)	2002-10-31
ZA200202220B (en)	2002-10-10
CN1185214C (zh)	2005-01-19
PT1245565E (pt)	2003-12-31
DK1245565T3 (da)	2004-01-12
ATE250578T1 (de)	2003-10-15
BR0200871A (pt)	2003-01-07

Similar Documents

Publication	Publication Date	Title
NO20013254L (no)	2001-12-31	Nye difenylureaforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske samensetninger som inneholder dem
NO20022285L (no)	2002-11-18	Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO996250D0 (no)	1999-12-16	Nye hydrazidforbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
NO20042805L (no)	2004-07-02	Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem
NO20052683D0 (no)	2005-06-03	Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20010522L (no)	2001-08-01	Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20026154D0 (no)	2002-12-20	Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20014945L (no)	2002-04-15	Nye cyklonbutendionforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20010305D0 (no)	2001-01-18	Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021198L (no)	2002-09-13	Nye isoindoloindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20013206D0 (no)	2001-06-26	Nye 1,1- og 1,2-disubstituerte cyklopropanforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem
NO20031643L (no)	2003-04-10	Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021330D0 (no)	2002-03-18	Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023389D0 (no)	2002-07-12	Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023345D0 (no)	2002-07-11	Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem
NO20013710L (no)	2002-01-29	Nye benzotiadiazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20016069D0 (no)	2001-12-12	Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem
NO20023409D0 (no)	2002-07-15	Nye N-benzylpiperazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20035215D0 (no)	2003-11-24	Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20021806L (no)	2002-10-21	Nye pyrimidin-4-on-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20041313L (no)	2004-10-11	Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20022794L (no)	2002-12-16	Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20020262D0 (no)	2002-01-17	Nye cykloheptenforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20011862L (no)	2001-10-15	Nye heterocykloalkylbenzocyklobutan- og heteroarylbenzocyklobutanforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem
NO20023390D0 (no)	2002-07-12	Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Legal Events

Date	Code	Title	Description
2010-11-01	MM1K	Lapsed by not paying the annual fees